๋ฉํ ์นด๋ฅด๋ฐ๋ชฐ
**๋ฉํ ์นด๋ฅด๋ฐ๋ชฐ(Methocarbamol)**์ ๊ตฌ์์ดํ๋ค์ ๊ณผ ๊ตฌ์กฐ์ ์ผ๋ก ๊ด๋ จ๋ ์ค์ถ์ฑ ๊ณจ๊ฒฉ๊ทผ ์ด์์ ์ ๋๋ค. ์์ํ์์๋ ๊ณจ๊ฒฉ๊ทผ์ ๊ธ์ฑ ์ผ์ฆ ๋ฐ ์ธ์์ฑ ์ํ๋ฅผ ์น๋ฃํ๊ณ ์ฌํ ๊ทผ์ก ๊ฒฝ๋ จ๊ณผ ๋จ๋ฆผ์ ๊ด๋ฆฌํ๋ ๋ฐ ๋๋ฆฌ ์ฌ์ฉ๋ฉ๋๋ค. **์์ ์์ :** * **๊ณ ์์ด์ ํผ๋ฉํธ๋ฆฐ(permethrin) ์ค๋ ** ๋ฐ ๊ฐ์์์ **์ง์ ์ ๋ฐ ๊ณฐํก์ด ๋ ์**(์: ๊ณฐํก์ด๊ฐ ํ ์์) ์ญ์ทจ ์ ์๋ช ์ ๊ตฌํ๋ ์ค์ฌ๋ฒ์ผ๋ก ๋งค์ฐ ํจ๊ณผ์ ์ด๋ฉฐ ์์ฃผ ์ฌ์ฉ๋ฉ๋๋ค. * ๊ฒฝ๊ตฌ์ฉ ๋ฐ ์ฃผ์ฌ์ฉ ์ ์ ๋ก ์ ๊ณต๋ฉ๋๋ค. * ์ฃผ์ฌ์ ์๋ ํด๋ฆฌ์ํธ๋ ๊ธ๋ฆฌ์ฝ(PEG) 300์ด ํฌํจ๋์ด ์์ด ๊ธฐ์กด์ ์ ์ฅ ๋ณ๋ฆฌ๋ฅผ ์ ํ์ํฌ ์ ์์ผ๋ฏ๋ก, ์ฌ๊ฐํ ์ ์ฅ ์งํ์ด ์๋ ํ์์๊ฒ๋ ์ ๋งฅ ์ฃผ์ฌ(IV) ์ฌ์ฉ์ ์ฃผ์ํ๊ฑฐ๋ ํผํด์ผ ํฉ๋๋ค. * ์์ถ๋ ๊ณจ๊ฒฉ๊ทผ์ ์ง์ ์ด์์ํค์ง ์์ผ๋ฉฐ ์ค์ถ ์ ๊ฒฝ๊ณ ์ต์ ๋ฅผ ํตํด ์์ฉํฉ๋๋ค.
์์ฉ ๊ธฐ์ : The exact mechanism of action of methocarbamol is not fully understood, but it is known to act centrally rather than peripherally. * **Central CNS Depression:** It is believed to cause skeletal muscle relaxation by general central nervous system depression, likely depressing polysynaptic reflexes in the **internuncial neurons** of the spinal cord. * **No Peripheral Action:** It has **no direct relaxant effects** on striated muscle, nerve fibers, or the motor endplate. * **Secondary Effects:** Produces a secondary sedative effect due to its generalized CNS depressant properties.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- Relief of moderate conditions ยท 44 mg/kg IV ยท IV ยท As directed ยท Administer half the estimated dose rapidly, then wait until animal starts to relax and continue administration to effect.
- Controlling severe effects of strychnine and tetanus ยท 55-220 mg/kg IV ยท IV ยท As directed ยท Do not exceed 330 mg/kg/day. Administer half the estimated dose rapidly, then wait until animal starts to relax and continue administration to effect.
- General muscle relaxation (Tablets) ยท Initially, 132 mg/kg/day PO divided q8h-q12h, then 61-132 mg/kg divided q8-12h ยท PO ยท q8h-q12h ยท Discontinue if no response in 5 days
- Adjunctive treatment (control of seizures/muscle tremors) of permethrin toxicity ยท initially administered at 50-150 mg/kg IV ยท IV ยท As directed ยท First half is given IV slowly over approximately 5-10 minutes and the second half of the dose being given as needed to effect. The dose can be repeated up to a maximum of 330 mg/kg/day; in severely affected cases, the total daily dose can be calculated and given over 24 hours as a constant rate infusion.
- General muscle spasms, tetanus, toxicities ยท 20-45 mg/kg ยท PO ยท q8h ยท As needed ยท Very high doses may be required for tetanus. Recommended not to exceed 330 mg/kg. Limited literature in cats.
- Moderate conditions ยท 4.4-22 mg/kg IV to effect ยท IV ยท As directed ยท ARCI UCGFS Class 4 Drug
- Severe conditions ยท 22-55 mg/kg IV ยท IV ยท As directed
- General muscle relaxation ยท 15-25 mg/kg IV by slow infusion ยท IV ยท As directed
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Food-producing animals
- Renal disease (injectable formulation only, due to PEG 300 vehicle)
- Known hypersensitivity to methocarbamol
- Subcutaneous (SC) administration
- No specific contraindications available, but use with caution in renal or hepatic impairment.
์ด์๋ฐ์
- Sedation
- Salivation
- Emesis
- Lethargy
- Weakness
- Ataxia
์ฝ๋ฌผ ์ํธ์์ฉ
- CNS Depressants (e.g., opioids, benzodiazepines, barbiturates) ยท Additive CNS depression may occur when given concurrently.
- Pyridostigmine ยท May cause severe weakness (reported in a human patient with myasthenia gravis).
- Other CNS depressants ยท Additive CNS depression ยท moderate
๋ชจ๋ํฐ๋ง
- Level of muscle relaxation
- Degree of sedation
- Respiratory rate and effort (especially with high IV doses or concurrent CNS depressants)
- Degree of muscle relaxation
- CNS depression/sedation levels
- Renal and hepatic function (if prolonged use)
๊ณผ์ฉ๋
**Signs of Toxicity:** Overdosage is generally characterized by profound CNS depressant effects, including loss of righting reflex and prostration. Excessive doses in dogs and cats may manifest as emesis, salivation, severe weakness, and ataxia. **Management:** * **Decontamination:** If the overdose occurred recently via oral administration, emptying the gut (e.g., emesis induction or gastric lavage) may be indicated. **Do not induce emesis** if the patient's continued consciousness and airway protection are not assured. * **Supportive Care:** Treat other clinical signs supportively if severe. Monitor respiratory and cardiovascular function closely.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.